Latest Patent News

Mylan settles patent litigation relating to Sunovion's Brovana productMylan Inc., a global pharmaceutical company committed to setting new standards in healthcare, announced that Mylan Specialty L.P., f/k/a Dey Pharma, LP, has entered into an agreement with Sunovion Pharmaceuticals Inc., f/k/a Sepracor Inc., to resolve...

Cleaning in Green, MyCleaningProducts.com Releases Products that Clean and Benefit the EnvironmentMyCleaningProducts.com introduced its line of non-toxic cleaners. The green online company assured consumers that its cleaning products work effectively without endangering anybody's health or harming the environment. Portland, OR (PRWEB) May 26, 2012 Cleaning is supposed to protect both health and the environment. However, many of today's cleaning products offer more danger than help. Breaki...

The Impact of Seed Policy Reforms and Intellectual Property Rights on Crop Productivity in IndiaAbstract. The growth of private investment in developing-country agriculture, new advances in the biological sciences, and rapid integration of developing countries into the global trading system has heightened interest in the topic of seed market and intellectual property rights’ (IPRs) policies among public policy-makers, corporate decision-makers and other actors in the agricultural sec...

Neptune narrows Q4 loss on strong segment growthNeptune Technologies & Bioressources (NASDAQ:NEPT) narrowed its fiscal fourth-quarter loss Friday amid strong revenues from its nutraceutical segment.The Quebec-based company develops and commercializes bioactive ingredients and products with cli...

Freeman Technology - New white paper: Quantifying the impact of humidity on powder properties

25 May 2012: Tewkesbury, UK: New experimental data from Freeman Technology demonstrate how dynamic, shear and bulk powder testing can be applied to quantify the impact of humidity on powder behaviour, supporting the need to develop effective strategies for moisture control and process optimisation. ‘Quantifying the impact of humidity on powder properties’ by Brian Armstrong (Powde...

Clements Worldwide Adds GlobalCare Plus PlanWASHINGTON, May 25, 2012 /PRNewswire/ -- Clements Worldwide has introduced GlobalCare® Plus, an international health insurance plan that allows people to choose any country worldwide for medical care treatment. The policy is uniquely designed for expatriates living or working abroad. "One of the purposes of GlobalCare® Plus is to minimize the patient's out-of-pocket expenses," said...

ConforMIS iTotal® CR Knee Replacement System Wins Silver in 2012 Medical Design Excellence AwardsPrivately-held ConforMIS, Inc. today announced that its iTotal® CR Knee Replacement System has been awarded Silver in the “Implant and Tissue-Replacement Products” category of the

15 South Korea Pharmas In Potential Battle With Pfizer Over Viagra GenericSouth Korea could become a battleground between local makers of generic drugs and Pfizer Inc. over the latter’s erectile-dysfunction drug Viagra (sildenafil) and its alleged patent protection.

Astellas Sues U.S.-Based Hospira For Infringing Adenocard PatentAstellas Pharma filed a suit against Hospira alleging the U.S. firm infringed on a patent for Adenocard (adenosine) for diagnosing heart blockage.

Watson Confirms Testim Patent ChallengeWatson Pharmaceuticals, Inc. has confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the FDA seeking approval to market Testosterone Gel, 1%. Watson's 1% testosterone gel product is a generi...

TB4 Provides Both Neuroprotection and Neurorestoration When Administered Shortly after Traumatic Brain Injury in Rat ModelRegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX) (“the Company” or “RegeneRx”) reported that data showing that Thymosin beta 4 (Tβ4) “provides both neuroprotection and neurorestoration after traumatic brain injury (TBI),” was published in the current (May 2012) edition of the Journal of Neurosurgery, 116:1081–1092. As re...

Eisai Plans More Global Cost Cuts In Wake Of Loss Of Aricept PatentEisai says it plans additional cost cuts by the end of the current fiscal year March, 2013, as a result of the patent-expiration of Alzheimer’s disease drug Aricept (donepezil).

Auxilium, FCB file patent infringement lawsuit against WatsonAuxilium Pharmaceuticals and FCB have filed a patent infringement lawsuit, related to Testim 1% testosterone gel, against Watson Laboratories, Watson Pharmaceuticals, and Watson Pharma.

Mylan Announces Settlement Agreement in Patent Infringement Litigation Relating to Sunovion's Brovana ProductPITTSBURGH, May 24, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that Mylan Specialty L.P., f/k/a Dey Pharma, L.P., has entered into an agreement with Sunovion Pharmaceuticals Inc., f/k/a Sepracor Inc., to resolve the parties'...

Eisai Launches Mobile Phone Patient Compliance Site For Reflux EsophagitisEisai hopes to protect RE treatment Pariet/AcipHex (rabeprazole) from post-patent competition.

Israel's Thrombotech and D-Pharm to mergeintellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, says that Thrombotech, a portfolio company in which Hadasit holds a 24.8% stake, has signed a merger agreement with D-Pharm (TASE: D...

Alnylam and PBL Sign Licence Agreement for Baulcombe & Hamilton RNAi patentAlnylam Pharmaceuticals, Inc. and Plant Bioscience Limited (PBL) announced that they have entered into a licensing agreement. PBL has granted Alnylam a world-wide, non-exclusive license to the Baulcombe patent (U.S. Patent No. 8,097,710) for use...

Rising Interest of Big Pharma Creates Immense Growth Potential for Contract Manufacturing Organisations, Says Frost & SullivanLONDON, May 25, 2012 /PRNewswire/ -- Increasingly, big pharma is viewing the outsourcing of pharmaceutical manufacturing as a strategic move that would enable them to focus on their core competencies such as R&D. At the same time, the patent expiry of key blockbuster drugs worth $45 billion and biologics worth $30 billion is expected to reduce the capacity utilisation rates of their manuf...

Rising Interest of Big Pharma Creates Immense Growth Potential for Contract Manufacturing Organisations, Says Frost & SullivanLONDON, May 25, 2012 /- Increasingly, big pharma is viewing the outsourcing of pharmaceutical manufacturing as a strategic move that would enable them to focus on their core competencies such as R&D. At the same time, the patent expiry of ke...

Mold Removal Edge for Bigger Profit, Molderizer.com Bares the Secret to Efficient and Low-Cost Mold Remediation ProcessGreen company Molderizer.com made available to the public its non-toxic mold removal product. Apart from an effective mold remediation process, the solution promises a safe treatment. St Louis, MO (PRWEB) May 25, 2012 In mold removal, the goal is to get rid of the fungi. However, even in a mold remediation process, the end does not justify the means. The execution of it must be safe apart from ef...

HK tycoon Lau rejects Macau corruption chargesA Hong Kong property tycoon insists he is innocent of bribery and money laundering charges filed against him over a land deal in the gambling hub of Macau.Chinese Estates Holdings Ltd. said late Thursday that Chairman Joseph Lau "strenuously denied...

Brookhaven Lab’s Adzic Named ‘Inventor of the Year’The New York Intellectual Property Law Association has honored senior chemist Radoslav Adzic for his extensive nanocatalyst research.

Apricus Biosciences Strengthens Vitaros(R) and Nexact(R) Patent Estate With Two New Patent AllowancesSAN DIEGO, May 25, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that the Canadian Intellectual Property Office issued a Notice of Allowance for a Canadian patent on certain methods of manufacture for the Company's platform NexACT® drug delivery technology. Specifically, the patent covers the synthe...

Study Validating miRview mets2 Published in The Oncologist PHILADELPHIA, PA and REHOVOT, ISRAEL -- (Marketwire) -- 05/25/12 -- Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostic tests, today announced that data from studies of miRview® mets² in patients with Cancer of Unknown and Uncertain Primary ("CUP") were published online in The Oncologist in an article titled, "A second generation microR...

MTBC Launches CareConnector(TM), a Patent-Pending System That Identifies and Proactively Schedules Important Healthcare EncountersSOMERSET, N.J., May 25, 2012 (GLOBE NEWSWIRE) -- MTBC, a leading healthcare IT company serving providers throughout the country, announced today the launch of CareConnector™, a proactive patient scheduling system that systematically identifies and addresses opportunities for optimizing patient care. As explained in MTBC's recent patent filing, "[CareConnector™] will not only determine which...

0 1 2 3 4 ›»

buy Patent market research data and corporate reports now Advertisement